D.E. Shaw & Co’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

D.E. Shaw & Co’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,606	Closed	-$41K	–	3937
2017 Q4	$41K	Buy	+24,606	New	+$42.3K	﹤0.01%	3539
2016 Q1	–	Sell	-3,409	Closed	-$127K	–	3965
2015 Q4	$127K	Buy	+3,409	New	+$150K	﹤0.01%	3649

Other funds holding ANTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's ANTH Position: Q1 2018 in Review

D.E. Shaw & Co sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 24,606 shares — an estimated $41K sold.

D.E. Shaw & Co first reported a position in ANTH in Q4 2015 and held it in 2 quarters. The position peaked at $127K in Q4 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

D.E. Shaw & Co reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
D.E. Shaw & Co sold 24,606 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $41K.
D.E. Shaw & Co first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2015 and held it in 2 quarters.
D.E. Shaw & Co's Anthera Pharmaceuticals, Inc. position peaked at $127K in Q4 2015.
28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.